Funds and ETFs BICO Group AB

Equities

BICO

SE0013647385

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 11:29:38 2024-04-26 am EDT 5-day change 1st Jan Change
45.6 SEK +2.89% Intraday chart for BICO Group AB +3.07% -19.94%

ETFs positioned on BICO Group AB

Name Weight AuM 1st Jan change Investor Rating
0.51% 16 M€ -8.49%
0.00% 34 M€ +2.14% -
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
45.6 SEK
Average target price
132.5 SEK
Spread / Average Target
+190.57%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BICO Stock
  4. Funds and ETFs BICO Group AB